Genetic variations in HMGCR and PCSK9 and kidney function: a Mendelian randomization study
Sehoon Park, Seong Geun Kim, Soojin Lee, Yaerim Kim, Semin Cho, Kwangsoo Kim, Yong Chul Kim, Seung Seok Han, Hajeong Lee, Jung Pyo Lee, Kwon Wook Joo, Chun Soo Lim, Yon Su Kim, Dong Ki Kim
Kidney Res Clin Pract. 2023;42(4):460-472.   Published online 2023 May 22     DOI: https://doi.org/10.23876/j.krcp.22.237
Citations to this article as recorded by Crossref logo
Insights into drug adverse reactions prediction through Mendelian randomization: a review
Zhuanqing Huang, Hui Gong, Xuemin Sun, Wenqi Yi, Shiyang Liang, Sen Yang, Qi Sun, Xiaochuan Yan
Postgraduate Medical Journal.2025;[Epub]     CrossRef
The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease
Meiyan Wu, Chang-Yun Yoon, Jimin Park, Gyuri Kim, Bo Young Nam, Seonghun Kim, Jung Tak Park, Seung Hyeok Han, Shin-Wook Kang, Tae-Hyun Yoo
Diabetologia.2024; 67(9): 1980.     CrossRef
Impact of hyperuricemia on CKD risk beyond genetic predisposition in a population-based cohort study
Yaerim Kim, Jinyeon Jo, Yunmi Ji, Eunjin Bae, Kwangbae Lee, Jin Hyuk Paek, Kyubok Jin, Seungyeup Han, Jung Pyo Lee, Dong Ki Kim, Chun Soo Lim, Sungho Won, Jeonghwan Lee
Scientific Reports.2024;[Epub]     CrossRef
Lipid-lowering drugs and risk of rapid renal function decline: a mendelian randomization study
Zhicheng Zhao, Yu Wan, Han Fu, Shuo Ying, Peng Zhang, Haoyu Meng, Yu Song, Naikuan Fu
BMC Medical Genomics.2024;[Epub]     CrossRef
Lipid-lowering and kidney
Sang-Hak Lee
Kidney Research and Clinical Practice.2023; 42(4): 412.     CrossRef